Karachi: Citi Pharma Ltd., a prominent entity in the pharmaceutical sector, has reported a significant acquisition of its shares by its Executive Director, Rizwan Ahmad. According to a disclosure made under the Pakistan Stock Exchange (PSX) Regulation 5.6.4, Mr. Ahmad executed a transaction to purchase an additional 2 million shares of the company.

The report, dated August 10, 2026, details that the transaction occurred on August 5, 2026, within the ready market. Mr. Ahmad acquired these shares at a rate of 74.66 per share. This purchase brings his cumulative holding to 56.03 million shares, representing a cumulative percentage of 24.52.

According to information available from the Pakistan Stock Exchange (PSX), this acquisition by the Executive Director marks a big move, classifying it as a notable shift in the shareholding structure of Citi Pharma Ltd. The transaction underscores Mr. Ahmad's increased interest in the company's growth and strategic direction.

Citi Pharma Ltd. continues to be a key player in the pharmaceutical industry, with its market activities closely monitored by investors and stakeholders. This recent development adds a new dimension to the company's shareholding dynamics, reflecting potential strategic interests and confidence in its future prospects.